1. Global Safety Pharmacology, Pfizer Inc., Groton, CT, USA
2. School of Physiology and Pharmacology, University of Bristol, Bristol, UK
3. Translational Safety, Drug Safety and Metabolism, Innovative Medicines and Early Development, AstraZeneca R&D, Macclesfield, UK
4. AnaBios Corporation, San Diego, CA, USA
5. Discovery Sciences, Innovative Medicines and Early Development, AstraZeneca R&D, Macclesfield, UK
6. Safety Assessment, GlaxoSmithKline, King of Prussia, PA, USA
7. Division of Applied Regulatory Science, CDER, US Food and Drug Administration, Silver Spring, MD, USA
8. Safety Pharmacology Society, Reston, VA, USA
9. Zenas Technologies LLC, New Orleans, LA, USA
10. Global Safety Pharmacology, Discovery Sciences, Janssen Research & Development LLC, Spring House, PA, USA
11. Center for Proteomic Chemistry, Novartis Institutes for BioMedical Research, Inc, Cambridge, MA, USA
12. Department of Integrative Pharmacology, Integrated Sciences & Technology, AbbVie, North Chicago, IL, USA
13. Department of Safety Assessment, Merck & Co, Kenilworth, NJ, USA
14. Division of Cardiovascular and Renal Products, CDER, U.S. Food and Drug Administration, Silver Spring, MD, USA
15. ChanTest, A Charles River Company, Cleveland, OH, USA
16. Bristol Myers Squibb Research & Development, Princeton, NJ, USA
17. Biolin Scientific, Ballerup, DK
18. Preclinical Safety, Sanofi, Bridgewater, NJ, USA
19. Global Cardiovascular Assessment, Eisai Co., Ltd., Ibaraki, Japan
20. Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, MD, USA
21. Victor Chang Cardiac Research Institute, St Vincent’s Clinical School, University of NSW, Darlinghurst, NSW, Australia